IDNA Holdings
62 holdings in the fund's latest file; the data source updated it on Oct 8, 2026.
Top 25 Holdings
| # | Holding | Weight | Shares (as reported) | Value (as reported) |
|---|---|---|---|---|
| 1 | MODERNA | 11.90% | 186,574 | $36.7M |
| 2 | TWIST BIOSCIENCE | 6.46% | 127,855 | $19.9M |
| 3 | IOVANCE BIOTHERAPEUTICS INC | 4.52% | 1,077,252 | $13.9M |
| 4 | GENMAB (GMAB.CO) | 4.34% | 35,890 | $13.4M |
| 5 | REVOLUTION MEDICINES | 3.87% | 59,288 | $11.9M |
| 6 | TAKEDA PHARMACEUTICAL (4502.T) | 3.41% | 287,800 | $10.5M |
| 7 | MERCK & CO INC | 3.40% | 73,275 | $10.5M |
| 8 | BAYER AG (BAYN.DE) | 3.38% | 211,774 | $10.4M |
| 9 | REGENERON PHARMACEUTICALS | 3.35% | 13,923 | $10.3M |
| 10 | IMMUNITYBIO | 3.31% | 1,045,708 | $10.2M |
| 11 | VERTEX PHARMACEUTICALS | 3.25% | 19,804 | $10.0M |
| 12 | EXELIXIS INC | 3.19% | 167,971 | $9.8M |
| 13 | INCYTE CORP | 3.18% | 86,446 | $9.8M |
| 14 | BIONTECH SE ADR | 3.11% | 100,485 | $9.6M |
| 15 | ROCHE PS PAR AG (ROP.SW) | 3.02% | 21,482 | $9.3M |
| 16 | CARIS LIFE SCIENCES | 3.00% | 340,550 | $9.2M |
| 17 | IDEAYA BIOSCIENCES | 2.72% | 230,940 | $8.4M |
| 18 | ABCELLERA BIOLOGICS | 2.71% | 651,264 | $8.4M |
| 19 | GLAXOSMITHKLINE (GSK.L) | 2.62% | 341,217 | $8.1M |
| 20 | SANOFI SA (SAN.PA) | 2.56% | 98,238 | $7.9M |
| 21 | IPSEN SA (IPN.PA) | 2.56% | 48,521 | $7.9M |
| 22 | ARCUS BIOSCIENCES | 1.85% | 232,583 | $5.7M |
| 23 | NOVAVAX | 1.58% | 434,617 | $4.9M |
| 24 | ONO PHARMACEUTICAL (4528.T) | 1.44% | 310,500 | $4.4M |
| 25 | VIR BIOTECHNOLOGY | 1.38% | 370,148 | $4.3M |
Sector Weights
- Healthcare: 100.00%
Country Weights
- United States: 66.14%
- Germany: 6.49%
- France: 5.55%
- Japan: 4.88%
- Switzerland: 4.37%
- Denmark: 4.26%
- Canada: 2.72%
- United Kingdom: 2.62%
- China: 1.87%
- Luxembourg: 0.60%
- South Korea: 0.29%
- Other: 0.22%
Shares, value and weight are as reported in the file, dated by the data source's last update of it (not the date of the positions), never adjusted; a split warning appears only for a split close to or after that date, and its absence does not mean the count is on today's share basis. Weights as the fund reports them. Leveraged and inverse funds list swaps and cash, so weights can be negative or add up past 100.